Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Blue Star Limited launches new range of ‘Best-in-Class Affordable’ room ACs

Blue Star Limited launches new range of ‘Best-in-Class Affordable’ room ACs

Here's the government's clarification on STT hike for trading in options

Here's the government's clarification on STT hike for trading in options

Tax relief for real estate, and infrastructure investments proposed in finance bill

Tax relief for real estate, and infrastructure investments proposed in finance bill

Nestle India Chairman says food inflation, recession to continue in 2023

Nestle India Chairman says food inflation, recession to continue in 2023

Mahindra acquires 7,67,59,301 shares of MAPL to make it a wholly-owned subsidiary

Mahindra acquires 7,67,59,301 shares of MAPL to make it a wholly-owned subsidiary